Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial

Background: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. Methods: The CRASH-3 trial random...

全面介紹

書目詳細資料
發表在:Critical Care
主要作者: Brenner A.; Belli A.; Chaudhri R.; Coats T.; Frimley L.; Jamaluddin S.F.; Jooma R.; Mansukhani R.; Sandercock P.; Shakur-Still H.; Shokunbi T.; Roberts I.
格式: Article
語言:English
出版: BioMed Central Ltd 2020
在線閱讀:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095781531&doi=10.1186%2fs13054-020-03243-4&partnerID=40&md5=15c5815a3482e941f90ef01220ef9d47